Potential Positives Teva Pharmaceuticals has achieved FDA approval and launched the first-ever generic GLP-1 product indicated for weight loss, enhancing market presence in a growing therapeutic category
With n=3 per group, meaningful statistical analysis is not possible Categorical outcome scale: Results were reported as improvement categories (025%, 2650%) rather than exact hair counts or measurements, making precise comparison with other studies difficult Industry funding: The study was funded by Highside Corp
For example, it was found that carnitine as a supplement may be used to treat diabetes mellitus (29, 30), liver cirrhosis (31), dyslipidemia (32), hypertension (33), heart failure (34), coronary artery disease (35), non-alcoholic fatty liver disease (36), Alzheimers disease (37), migraine (38), and muscle injury (39)
CLINICAL APPLICATIONS Improves Cellular Energy Production Stimulates Fat Utilization and Boosts Metabolism Promotes Cardiovascular Health Supports Post-Training Muscle Recovery Overview Produced in the body from L-lysine and L-methionine, the synthesis of L-carnitine requires optimal amounts of other key nutrients including niacin, pyridoxine, vitamin C and iron for synthesis